Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Poseida Therapeutics
4242 Campus Point Court, Suite 700
San Diego, CA 92121
Phone: 858-779-3100
https://poseida.com

Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. P-BCMA-101 is Poseida's lead CAR-T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma.

Key Contact
NameTitleE-Mail
Eric OstertagCEOeostergag@poseida.com


Funding Events
DateAmountTypeInvestors
04/05/18$30,500,000Series B Longitude Capital  
Malin Corporation
Tavistock Group
Vivo Capital
04/22/19$142,000,000Series C Aisling Capital
Boxer Capital
Longitude Capital
Malin Corporation
Novartis Venture Funds  
Pentwater Capital Management
Perceptive Advisors
Vivo Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.